- Home
- BIVI vs LRE Comparison
BIVI vs LRE Comparison
Compare BIVI & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- LRE
- Stock Information
- Founded
- BIVI 2013
- LRE 2001
- Country
- BIVI United States
- LRE Japan
- Employees
- BIVI N/A
- LRE N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- BIVI Health Care
- LRE
- Exchange
- BIVI Nasdaq
- LRE Nasdaq
- Market Cap
- BIVI 18.6M
- LRE 17.6M
- IPO Year
- BIVI N/A
- LRE 2023
- Fundamental
- Price
- BIVI $0.97
- LRE N/A
- Analyst Decision
- BIVI
- LRE
- Analyst Count
- BIVI 0
- LRE 0
- Target Price
- BIVI N/A
- LRE N/A
- AVG Volume (30 Days)
- BIVI 210.2K
- LRE 14.8K
- Earning Date
- BIVI 05-12-2025
- LRE 01-01-0001
- Dividend Yield
- BIVI N/A
- LRE N/A
- EPS Growth
- BIVI N/A
- LRE N/A
- EPS
- BIVI N/A
- LRE N/A
- Revenue
- BIVI N/A
- LRE $110,330,328.00
- Revenue This Year
- BIVI N/A
- LRE N/A
- Revenue Next Year
- BIVI N/A
- LRE N/A
- P/E Ratio
- BIVI N/A
- LRE N/A
- Revenue Growth
- BIVI N/A
- LRE 8.82
- 52 Week Low
- BIVI $0.62
- LRE $1.10
- 52 Week High
- BIVI $7.50
- LRE $2.49
- Technical
- Relative Strength Index (RSI)
- BIVI 42.25
- LRE 57.65
- Support Level
- BIVI $0.88
- LRE $1.71
- Resistance Level
- BIVI $1.03
- LRE $2.11
- Average True Range (ATR)
- BIVI 0.07
- LRE 0.12
- MACD
- BIVI -0.02
- LRE -0.01
- Stochastic Oscillator
- BIVI 23.97
- LRE 34.69
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.